Canada · Series D startup

Who invested in DalCor Pharmaceuticals

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Genomics

Funding summaryUpdated 26 Oct 2026

$80Mraised across 1 round since 2023, from 1 source

Latest round
Series D, $80MSept 2023
Investors
1
See who backed them

The rounds

  1. Sept 2023
    Series D$80M

    Source recorded

Founders and team

From DalCor Pharmaceuticals's own website: 3 on the team.

  • Peter SchuepbachVice President, Technical Operations
  • Ramy HobeikaVICE PRESIDENT, Finance
  • Diane SullivanChief Commercial Officer

Everyone who backed them

Investissement QuebecInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about DalCor Pharmaceuticals

Who invested in DalCor Pharmaceuticals?

DalCor Pharmaceuticals's investors include Investissement Quebec.

How much has DalCor Pharmaceuticals raised?

DalCor Pharmaceuticals has raised $80M across 1 round since 2023.

When did DalCor Pharmaceuticals last raise?

DalCor Pharmaceuticals's most recent round was a Series D of $80M in Sept 2023.

What was DalCor Pharmaceuticals's biggest round?

Its most recent round, $80M in Sept 2023, is also its largest on record.

Who backed DalCor Pharmaceuticals first?

DalCor Pharmaceuticals's first round on record, in Sept 2023, was backed by Investissement Quebec.

What stage is DalCor Pharmaceuticals at?

DalCor Pharmaceuticals's latest named round is a Series D, in Sept 2023.

Where is DalCor Pharmaceuticals based?

DalCor Pharmaceuticals is based in Canada.

Companies like DalCor Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.